This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
On November 5, I was selected by the AAN Board of Directors to be Editor-in-Chief of the journal after an international search that began in June 2009 after John H. Noseworthy, MD, FAAN, resigned to become president and CEO of Mayo Clinic. It has been my pleasure and privilege to have served as an Associate and Deputy Editor with two visionary Editors-in-Chief, Drs. Robert C. Griggs and Noseworthy. Under their aegis, the journal has gone from strength to strength. I am thrilled with this appointment and the opportunity to continue my relationship with the journal and the AAN.
STATE OF THE JOURNAL AND FUTURE PLANS
Our mission and vision remain the same, embodied in our strategic plan,1 and serve as the philosophical core of our work on behalf of our readers. We will pursue the journal's mission—Neurology® will provide neurologists with outstanding peer-reviewed articles, editorials, and reviews to enhance patient care, education, clinical research, and professionalism—and vision—Neurology will be the premier peer-reviewed journal for clinical neurologists. It naturally follows that our goals are to achieve the highest levels of author and reader satisfaction; growth in our markets, including foreign language editions; improvement of journal metrics as indicators of the importance of our articles, embodied in the impact factor, Eigenfactor™, and PERQ scores2; the shortest time to decision and publication; and, equally important, mission-advancing financial performance. In addition to maintaining the progress made on journal initiatives to date, the editorial team will seek ways to enhance them and to institute new initiatives, such as expanded e-publishing.
-
The efficiency of the review process is improved. We now receive nearly 4,000 manuscripts per year, but decisions are made in 28–29 days, compared to 42 days in 2006. The time between acceptance and publication has narrowed to 9–12 weeks. The quality of our manuscripts has …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg